1. Home
  2. STNE vs IMNM Comparison

STNE vs IMNM Comparison

Compare STNE & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo StoneCo Ltd.

STNE

StoneCo Ltd.

HOLD

Current Price

$11.15

Market Cap

2.7B

Sector

Technology

ML Signal

HOLD

Logo Immunome Inc.

IMNM

Immunome Inc.

HOLD

Current Price

$23.21

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STNE
IMNM
Founded
2012
2006
Country
Cayman Islands
United States
Employees
N/A
N/A
Industry
EDP Services
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.5B
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
STNE
IMNM
Price
$11.15
$23.21
Analyst Decision
Buy
Strong Buy
Analyst Count
7
10
Target Price
$19.07
$32.80
AVG Volume (30 Days)
3.7M
1.3M
Earning Date
05-14-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
51.40
EPS
N/A
N/A
Revenue
N/A
$6,941,000.00
Revenue This Year
$15.07
N/A
Revenue Next Year
$6.05
$1,127.34
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.45
$8.67
52 Week High
$19.95
$27.65

Technical Indicators

Market Signals
Indicator
STNE
IMNM
Relative Strength Index (RSI) 52.44 58.25
Support Level $10.45 $19.28
Resistance Level $11.62 $23.25
Average True Range (ATR) 0.34 1.11
MACD -0.01 -0.09
Stochastic Oscillator 72.31 45.52

Price Performance

Historical Comparison
STNE
IMNM

About STNE StoneCo Ltd.

StoneCo Ltd is a provider of financial technology solutions. It serves MSMBs solutions, at fair prices, and provides the customer experience to help them manage their businesses and sell more. Its Stone Business Model combines end-to-end, cloud-based technology platforms; differentiated hyper-local and integrated distribution approaches; and white-glove, on-demand customer service. The brands of the company include: Stone: For small and medium-sized businesses, all management is integrated with the payment terminal, business bank account, and card, all within the same app. Ton: For micro-entrepreneurs and freelancers, modern card machines, sales via Pix or TapTon, and a Super Account. Stone pagar.me for those who sell online. Digital payment technology for all types of businesses.

About IMNM Immunome Inc.

Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics. Its pipeline includes varegacestat, an investigational oral gamma secretase inhibitor that reported positive topline results in the Phase 3 RINGSIDE trial for progressing desmoid tumors; IM-1021, a ROR1 antibody-drug conjugate under evaluation in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand therapy with IND clearance and a planned Phase 1 trial. The company is also advancing preclinical solid tumor ADCs, including IM-1617, IM-1340, and IM-1335.

Share on Social Networks: